Blog

New Venture News: 100-Day Workout, KaiNexus drive big savings at Vanderbilt

Some powerful work is going on behind the walls of Vanderbilt Children's Hospital Outpatient Center. The Center embarked on a 100-Day Workout to identify ways they could improve internal processes.


New Venture News: InvisionHeart makes strong pitch at DEMO Day

InvisionHeart CEO Josh Nickols, PhD, had entrepreneurs and investors talking after pitching his smart ECG-based company at JumpStart Foundry’s DEMO Day.


LaunchTN offers help in writing SBIR and STTR grants

Help is here for researchers and entrepreneurs interested in applying for an SBIR or STTR grant (Small Business Innovative Research and Small Business Technology Transfer, respectively).


Sign up now for the New Venture Valuation Seminar

CTTC will host a New Ventures Valuation seminar in conjunction with the Cool Springs Life Sciences Center. If you have developed valuable technology that you believe might be the basis of a startup and want to understand how they are valued, make plans now to join us and learn more about the valuation process. 


Glenn Perdue talks valuation vs. price

Earlier this week, a crowd of roughly 40 business men and women, researchers, and entrepreneurs - including a handful from CTTC - listened intently as Glenn Perdue, managing member of Kraft Analytics, LLC and certified valuation analyst, shared insight into the intellectual property and new venture valuation process.


VU@EC: Engineering student grabs first seat

At just 20 years old, Vanderbilt engineering student Ben Whittle has become the first candidate accepted into the VU@EC program.


New Venture valuation seminar set for July 23

Understanding the valuation of early-stage businesses and related intellectual property is critical for new business ventures.  This information helps determine business strategy, financial modeling and the overall potential for a business.


KIYATEC signs deal, will explore potential of Vanderbilt technology

Vanderbilt University signed an option and limited license agreement with KIYATEC, a company dedicated to commercializing 3D cell culture technologies.


What we’ve learned from sequestration

When the sequester hit a few months ago, it hit. Academia and the healthcare industry both took significant punches.